BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsSupply of Breyanzi CAR-T Cell Therapy Products
    Awarded contract

    Supply of Breyanzi CAR-T Cell Therapy Products

    Awarded
    £140.3k
    Published 17 Aug 2026

    NHS England is seeking to procure Breyanzi CAR-T cell therapy products for direct supply to authorized healthcare providers.

    🇬🇧United Kingdom· North WestPublished 17 Aug 2026· 5 days agoviaFind a Tender
    Awarded
    £140.3k
    Published 17 Aug 2026

    Decision brief

    4 fields
    • Contract value
      £140,250
      Pounds sterling
    • Closing date
      Rolling
      No closing date published
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇬🇧United Kingdom
      North West

    Suppliers

    1 supplier
    • BS
      BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED
    Lead contractor

    Lifecycle

    Awarded

    Contract awarded. Originally published 5 days ago.

    17 August 2026
    Awarded — no open tender advertised

    Brief

    This is a procurement opportunity for the supply of Breyanzi CAR-T cell therapy products, which will be sourced directly from the manufacturer and commissioned through NHS England. Breyanzi is an approved cellular immunotherapy used in the treatment of certain blood cancers. Suppliers should be authorized distributors or manufacturers capable of meeting NHS England's quality standards, regulatory requirements, and delivery specifications for this specialized pharmaceutical product. The contract will involve direct supply arrangements with appropriate cold chain logistics and compliance with all relevant healthcare regulations.

    Track record

    1 award · 1 winner
    Thin record

    Only 1 prior award here — too little to read.

    In healthcare medical, The Clatterbridge Cancer Centre NHS Foundation Trust has awarded 1 contract to 1 supplier.

    Who wins here
    1. BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED1× · 100%

    Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.

    More from The Clatterbridge Cancer Centre NHS Foundation Trust

    4 listingsView all →
    AwardedFacilities Management🇬🇧United Kingdom

    Medical Equipment and Inspection Services

    Procurement for medical device repair and inspection services from experienced, qualified vendors.

    £14,585The Clatterbridge Cancer Centre NHS Foundation Trust
    Published 13 Aug 2026
    AwardedFacilities Management🇬🇧United Kingdom

    Arjo PPM Service Contract

    Service contract opportunity providing preventive maintenance and technical support for Arjo medical equipment and systems.

    £12,616The Clatterbridge Cancer Centre NHS Foundation Trust
    Published 13 Aug 2026
    AwardedFacilities Management🇬🇧United Kingdom

    Non-Contractual Reactive Works

    Opportunity to provide flexible reactive maintenance and repair services on an as-needed basis through the CCC-P program.

    £10,188The Clatterbridge Cancer Centre NHS Foundation Trust
    Published 13 Aug 2026
    AwardedEngineering🇬🇧United Kingdom

    High Voltage Substation Connection Services

    Procurement for specialized connection services and installation work at high voltage electrical substations.

    £261,219The Clatterbridge Cancer Centre NHS Foundation Trust
    Published 5 Aug 2026

    Open in Healthcare & Medical

    4 open listingsView all →
    Healthcare & Medical🇬🇧United Kingdom

    Early Cancer Diagnostic Technologies Development Programme

    Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.

    est.£25,400,000
    Published 1 Sept 2026
    Healthcare & Medical🇬🇧United Kingdom

    Clinical Validation of Early Cancer Diagnostic Technologies

    Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.

    est.£25,400,000
    Published 1 Sept 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Doxycycline 10-Pack Supply - Market Engagement 2027

    UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.

    £1nominalSecretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
    Published 21 Aug 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Patient Diagnostic and Monitoring Electrodes - Market Engagement Survey

    Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.

    Business Services Organisation Procurement and Logistics
    Published 21 Aug 2026
    Take action
    View on sourceFind a Tender

    Award notice and full record on the publisher's site

    Publisher
    UK Cabinet Office
    Licence
    OGL v3.0
    Source
    find-tender.service.gov.uk
    Record ID
    ocds-h6vhtk-06e577
    CC
    Buyer
    The Clatterbridge Cancer Centre NHS Foundation Trust
    Sector
    Healthcare & Medical